DURHAM, N.C., May 14, 2024 (GLOBE NEWSWIRE) -- Tavros Therapeutics, Inc., a precision oncology platform company, today announced that the Company has achieved two milestone payments in its ...

DURHAM, N.C. and SAN DIEGO, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Tavros Therapeutics, Inc., a precision oncology platform company leading the new frontier of targeted therapies exploiting tumors ...

The Californian biotech has partnered with Tavros Therapeutics to find four cancer targets, paying out $17.5 million cash with potentially up to $430.5 million to follow in biobucks. While those ...